- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00564109
Are the Pancreatic Serum Proteins Pancreatic Stone Protein (PSP) and Pancreatitis-Associated Protein (PAP) Predictive for the Development of Sepsis? Retrospective Study in Trauma Patients With Soft Tissue Defects.
March 17, 2008 updated by: University of Zurich
Retrospective analysis of PSP- and PAP-serum levels in trauma patients with soft tissue defects and possible correlation with the incidence and onset of infection and sepsis.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zurich, Switzerland
- Recruiting
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Trauma patients
Description
Inclusion criteria:
- Trauma patients submitted to the university hospital Zurich, aged 18-65 with soft tissue defects
Exclusion criteria:
- Patients with known immunocompromising illnesses, drug abuse or infectious diseases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2005
Study Completion
January 1, 2008
Study Registration Dates
First Submitted
November 26, 2007
First Submitted That Met QC Criteria
November 26, 2007
First Posted (Estimate)
November 27, 2007
Study Record Updates
Last Update Posted (Estimate)
March 18, 2008
Last Update Submitted That Met QC Criteria
March 17, 2008
Last Verified
November 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- StV 10-2003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trauma Patients With Soft Tissue Defects
-
The Affiliated Hospital of Xuzhou Medical UniversityCompletedTrauma Patients with Soft Tissue DefectsChina
-
British University In EgyptRecruitingSoft Tissue Thickness Around Delayed Implants in Patients With Thin Gingival PhenotypeEgypt
-
Sohag UniversityRecruitingReconstruction of Head Soft Tissue Defects | Reconstruction of Neck Soft Tissue DefectsEgypt
-
Aroa Biosurgery LimitedCoalition for National Trauma ResearchRecruitingSoft Tissue Defects | Soft Tissue Wounds | Traumatic Soft Tissue DefectUnited States
-
inSoma Bio, Inc.CompletedSubcutaneous Injection | Soft Tissue | Soft Tissue DefectsUnited States
-
Sohag UniversityRecruitingPost Tumor Excision Soft Tissue Defects | Post Debridement Soft Tissue Defects | Post Traumatic Soft Tissue Defects That Could be Reached by Pedicled Anterolateral Thigh FlapEgypt
-
Sohag UniversityNot yet recruitingSOFT TISSUE DEFECTSEgypt
-
Aswan UniversityRecruitingCoverage of Soft Tissue DefectsEgypt
-
The Affiliated Hospital of Xuzhou Medical UniversityCompletedPerforator Flap | Soft Tissue DefectsChina
-
Peking Union Medical College HospitalNot yet recruitingEfficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
Clinical Trials on retrospective Observation
-
Sheffield Children's NHS Foundation TrustCompleted
-
Ascension Macomb-Oakland HospitalCompletedHeart Failure | Preserved Ejection FractionUnited States
-
The First Hospital of Jilin UniversityCompleted
-
RwHealthNorthern Care Alliance NHS Foundation Trust; Alnylam PharmaceuticalsNot yet recruitingHereditary Amyloidosis | Guillain-Barre Syndrome | Chronic Inflammatory Demyelinating PolyneuropathyUnited Kingdom
-
Assaf-Harofeh Medical CenterUnknownDiabetes | Diabetic Nephropathy | Renal ProtectionIsrael
-
Europainclinics z.ú.University Hospital Bratislava; Slovak Academy of Sciences; R-CLINIC s.r.o.; Faculty...Recruiting
-
Samsung Medical CenterCompletedPercutaneous Coronary Intervention | Erythrocyte Transfusion | RevascularizationKorea, Republic of
-
University of Texas Southwestern Medical CenterCompletedDiabetic Foot UlcerUnited States
-
Cukurova UniversityToros UniversityActive, not recruitingLaparoscopic CholecystectomyTurkey (Türkiye)
-
Ajman UniversityCompletedTreatmentUnited Arab Emirates